Therapeutic Opportunities for Muscarinic Receptors in the Central Nervous System
Top Cited Papers
- 1 November 2000
- journal article
- review article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 43 (23) , 4333-4353
- https://doi.org/10.1021/jm990607u
Abstract
No abstract availableThis publication has 180 references indexed in Scilit:
- Immunological localization of m1–m5 muscarinic acetylcholine receptors in peripheral tissues and brainPublished by Elsevier ,2002
- The M5 (m5) receptor subtype: Fact or fiction?Life Sciences, 1997
- Muscarinic mechanisms in nerve cellsLife Sciences, 1997
- Molecular Biology of Muscarinic Acetylcholine ReceptorsCritical Reviews™ in Neurobiology, 1996
- A Possible Role of Tyrosine Kinases in the Regulation of Muscarinic Receptor-Activated Cation Channels in Guinea-Pig IleumBiochemical and Biophysical Research Communications, 1994
- Cholinergic and serotonergic stimulation of phosphoinositide hydrolysis is decreased in Alzheimer's diseaseLife Sciences, 1994
- A novel muscarinic receptor ligand which penetrates the blood brain barrier and displays in vivo selectivity for the m2 subtypeLife Sciences, 1993
- WAL 2014 - A muscarinic agonist with preferential neuron-stimulating propertiesLife Sciences, 1993
- Tetrahydroaminoacridine–Lecithin Combination Treatment in Patients with Intermediate-Stage Alzheimer's DiseaseNew England Journal of Medicine, 1990
- Elevation of acetylcholine levels in striatum of rat brain by LY163502, trans−(−)−5,5a,6,7,8,9a,10-octahydro-6-propylpyrimido〈4,5−g〉quinolin-2- amine dihydrochloride, a potent and stereospecific dopamine (D2) agonistLife Sciences, 1986